Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
25,588,124
-
Share change
-
+886,845
-
Total reported value
-
$5,300,261,339
-
Put/Call ratio
-
67%
-
Price per share
-
$207.17
-
Number of holders
-
341
-
Value change
-
+$188,038,650
-
Number of buys
-
163
-
Number of sells
-
146
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2018
As of 30 Jun 2018,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
341 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,588,124 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, DEUTSCHE BANK AG\, VICTORY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, and Bank of New York Mellon Corp.
This page lists
341
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.